Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma. [electronic resource]
Producer: 20060824Description: 425-6 p. digitalISSN:- 1592-8721
- Aged
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- therapeutic use
- Cytarabine -- therapeutic use
- Dexamethasone -- therapeutic use
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- Lymphoma, Mantle-Cell -- drug therapy
- Male
- Middle Aged
- Rituximab
- Survival Rate
- Transplantation, Autologous
No physical items for this record
Publication Type: Comparative Study; Letter
There are no comments on this title.
Log in to your account to post a comment.